FdaApplication
NDA 204096
Identifiers
- fda_app_no: NDA204096
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA US INC |
| application_type | NDA |
| approval_date | 2013-07-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ASTAGRAF XL | TACROLIMUS | EQ 1MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| ASTAGRAF XL | TACROLIMUS | EQ 0.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| ASTAGRAF XL | TACROLIMUS | EQ 5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
3 products